Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. 1988

J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

Transgenic mice containing intact copies of the human immunodeficiency virus (HIV) proviral DNA were constructed. Founder animals were not viremic for HIV and remained healthy during a 9-month observation period. After being mated with nontransgenic animals, one founder mouse (No. 13) gave rise to F1 progeny that developed a disease syndrome characterized by marked epidermal hyperplasia, lymphadenopathy, splenomegaly, pulmonary lymphoid infiltrates, growth retardation, and death by day 25 of life. Infectious HIV, indistinguishable from parental virus by immunoblot analysis, was recovered from the spleen, lymph nodes, and skin of five of five affected animals.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004817 Epidermis The external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: (1) basal layer (stratum basale epidermidis); (2) spinous layer (stratum spinosum epidermidis); (3) granular layer (stratum granulosum epidermidis); (4) clear layer (stratum lucidum epidermidis); and (5) horny layer (stratum corneum epidermidis).
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
September 1990, Gastroenterologia Japonica,
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
August 1996, AIDS research and human retroviruses,
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
January 2005, AIDS (London, England),
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
April 2004, Virology,
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
January 1988, Annals of neurology,
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
August 1975, Proceedings of the National Academy of Sciences of the United States of America,
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
January 2017, The open microbiology journal,
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
June 2003, Journal of acquired immune deficiency syndromes (1999),
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
January 1999, Methods in molecular medicine,
J M Leonard, and J W Abramczuk, and D S Pezen, and R Rutledge, and J H Belcher, and F Hakim, and G Shearer, and L Lamperth, and W Travis, and T Fredrickson
July 2000, Journal of dental research,
Copied contents to your clipboard!